ESMO 2026: Merck’s Kelun-partnered ADC hits the ‘Goldilocks zone,’ VP says
Twelve years ago, Merck won FDA approval for the PD-1 inhibitor Keytruda, heralding a new era of cancer treatment—and opening…
Twelve years ago, Merck won FDA approval for the PD-1 inhibitor Keytruda, heralding a new era of cancer treatment—and opening…